The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Cardiovascular Medicine
(Nov 2022)
Editorial: Clinical prospective of SGLT2 inhibitors in atherosclerosis
Annalisa Capuano,
Emilio Clementi,
Giuseppe Paolisso,
Giuseppe Paolisso
Affiliations
Annalisa Capuano
Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”, Naples, Italy
Emilio Clementi
Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy
Giuseppe Paolisso
Department of Advanced Medical and Clinical Science, University of Campania “Luigi Vanvitelli”, Naples, Italy
Giuseppe Paolisso
Mediterranea Cardiocentro, Naples, Italy
DOI
https://doi.org/10.3389/fcvm.2022.1040649
Journal volume & issue
Vol. 9
Abstract
Read online
No abstracts available.
Keywords
atherosclerosis
SGLT2 inhibitors
cardiovascular diseases
acute myocardial infarction
heart failure
peripheral artery diseases
WeChat QR code
Close